Troubling new details emerge on diabetes ouster controversy
Last month, we reported on a troubling incident at the annual meeting of the American Diabetes Association (ADA) in New Orleans. On June 5, five leading scientists were ousted for handing out copies of an editorial, published in the journal Diabetes Care (an ADA journal) in April, sharply criticizing the Trump administration’s ongoing attacks on scientific research.
Reported by 1 outlet — Ars Technica. See all sources ↓
Last month, we reported on a troubling incident at the annual meeting of the American Diabetes Association (ADA) in New Orleans. On June 5, five leading scientists were ousted for handing out copies of an editorial, published in the journal Diabetes Care (an ADA journal) in April, sharply criticizing the Trump administration’s ongoing attacks on scientific research. There was a public outcry and (eventually) a personal apology from the ADA's CEO for the heavy-handed response, but it seems the organization has not yet learned its lesson. The deputy editors of Diabetes Care have posted an editorial and seven accompanying opinion articles to a preprint server—handily contained in a single PDF file—that they say the ADA has refused to publish.
Read the full report at Ars Technica ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
- What's the story?
- Last month, we reported on a troubling incident at the annual meeting of the American Diabetes Association (ADA) in New Orleans. On June 5, five leading scientists were ousted for handing out copies of an editorial, published in the journal Diabetes Care (an ADA journal) in April, sharply criticizing the Trump administration’s ongoing attacks on scientific research.
- How widely is it covered?
- 1 outlet, average source rating 7.0/10.
- When was it last updated?
- 1m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Troubling new details emerge on diabetes ouster controversy
Sources1TypeCoverageArs Technica